外周血淋巴细胞亚群对静脉注射免疫球蛋白无反应型川崎病患儿的预测价值

薛燕; 尹晶; 许俐; 党利亨; 王朝; 崔亚琼; 张新杰; 李崇巍

doi:10.7499/j.issn.1008-8830.2305067

PDF(586 KB)

HTML

中国当代儿科杂志 ›› 2023, Vol. 25 ›› Issue (12) : 1211-1218. DOI: 10.7499/j.issn.1008-8830.2305067

川崎病专栏

外周血淋巴细胞亚群对静脉注射免疫球蛋白无反应型川崎病患儿的预测价值

薛燕¹, 尹晶², 许俐¹, 党利亨¹, 王朝¹, 崔亚琼¹, 张新杰¹, 李崇巍²

作者信息 +

Predictive value of peripheral blood lymphocyte subsets for children with intravenous immunoglobulin-resistant Kawasaki disease

XUE Yan, YIN Jing, XU Li, DANG Li-Heng, WANG Chao, CUI Ya-Qiong, ZHANG Xin-Jie, LI Chong-Wei

Author information +

文章历史 +

摘要

目的基于外周血淋巴细胞亚群及常见实验室检查指标，构建静脉注射免疫球蛋白（intravenous immunoglobulin, IVIG）无反应型川崎病（Kawasaki disease, KD）预测评分体系。方法纳入2021年1月—2023年3月于天津市儿童医院住院的KD患儿为研究对象（IVIG敏感型185例，IVIG无反应型41例）。选取年龄、性别匹配的健康儿童46例为对照。采用流式细胞仪检测外周血淋巴细胞亚群比例和绝对计数。采用多因素logistic回归分析探讨IVIG无反应型KD的预测因素，并构建IVIG无反应型KD预测评分体系。结果多因素logistic回归分析显示，CD4⁺T细胞绝对计数、自然杀伤细胞绝对计数、血清钠水平、球蛋白水平及总胆红素水平是IVIG无反应型KD的预测因素（P<0.05）。基于这些预测因素建立的IVIG无反应型KD的预测评分体系的灵敏度为70.7%，特异度为83.8%。结论外周血淋巴细胞亚群可作为儿童IVIG无反应型KD的预测指标；引入该指标建立的评分体系对预测儿童IVIG无反应型KD有较高的准确度。

Abstract

Objective Based on peripheral blood lymphocyte subsets and common laboratory test indexes, this study aimed to construct a predictive scoring system for intravenous immunoglobulin (IVIG)-resistant Kawasaki disease (KD). Methods Children hospitalized in Tianjin Children's Hospital from January 2021 to March 2023 were included in the study (185 cases of IVIG-sensitive KD and 41 cases of IVIG -resistant KD). Forty-six healthy children matched for age and gender were selected as controls. The relative percentage and absolute counts of peripheral lymphocyte subsets were measured by flow cytometry. Multivariate logistic regression was used to identify the predictive factors for IVIG-resistant KD and to construct a predictive scoring system for predicting IVIG-resistant KD. Results The multivariate logistic regression analysis showed that CD4⁺ T cell absolute count, natural killer cell absolute count, serum sodium level, globulin level, and total bilirubin level were identified as predictive factors for IVIG-resistant KD (P<0.05). The predictive scoring system based on these factors achieved a sensitivity of 70.7% and a specificity of 83.8% in predicting IVIG-resistant KD. Conclusions Peripheral blood lymphocyte subsets can serve as predictive indicators for IVIG-resistant KD in children. The introduction of this indicator and the establishment of a scoring system based on it can provide a higher accuracy in predicting IVIG-resistant KD in children.

导出引用

薛燕, 尹晶, 许俐, 党利亨, 王朝, 崔亚琼, 张新杰, 李崇巍. 外周血淋巴细胞亚群对静脉注射免疫球蛋白无反应型川崎病患儿的预测价值[J]. 中国当代儿科杂志. 2023, 25(12): 1211-1218 https://doi.org/10.7499/j.issn.1008-8830.2305067

XUE Yan, YIN Jing, XU Li, DANG Li-Heng, WANG Chao, CUI Ya-Qiong, ZHANG Xin-Jie, LI Chong-Wei. Predictive value of peripheral blood lymphocyte subsets for children with intravenous immunoglobulin-resistant Kawasaki disease[J]. Chinese Journal of Contemporary Pediatrics. 2023, 25(12): 1211-1218 https://doi.org/10.7499/j.issn.1008-8830.2305067

参考文献

1 Brogan P, Burns JC, Cornish J, et al. Lifetime cardiovascular management of patients with previous Kawasaki disease[J]. Heart, 2020, 106(6): 411-420. PMID: 31843876. PMCID: PMC7057818. DOI: 10.1136/heartjnl-2019-315925.
2 陕西省川崎病诊疗中心, 陕西省儿童内科疾病临床医学研究中心, 陕西省人民医院儿童病院, 等. 静脉输注免疫球蛋白在儿童川崎病中应用的专家共识[J]. 中国当代儿科杂志, 2021, 23(9): 867-876. PMID: 34535199. PMCID: PMC8480171. DOI: 10.7499/j.issn.1008-8830.2107110.
3 Ae R, Abrams JY, Maddox RA, et al. Corticosteroids added to initial intravenous immunoglobulin treatment for the prevention of coronary artery abnormalities in high-risk patients with Kawasaki disease[J]. J Am Heart Assoc, 2020, 9(17): e015308. PMID: 32811256. PMCID: PMC7660775. DOI: 10.1161/JAHA.119.015308.
4 Hamada H, Suzuki H, Onouchi Y, et al. Efficacy of primary treatment with immunoglobulin plus ciclosporin for prevention of coronary artery abnormalities in patients with Kawasaki disease predicted to be at increased risk of non-response to intravenous immunoglobulin (KAICA): a randomised controlled, open-label, blinded-endpoints, phase 3 trial[J]. Lancet, 2019, 393(10176): 1128-1137. PMID: 30853151. DOI: 10.1016/S0140-6736(18)32003-8.
5 Hedrich CM, Schnabel A, Hospach T. Kawasaki disease[J]. Front Pediatr, 2018, 6: 198. PMID: 30042935. PMCID: PMC6048561. DOI: 10.3389/fped.2018.00198.
6 Noval Rivas M, Lee Y, Wakita D, et al. CD8+ T cells contribute to the development of coronary arteritis in the Lactobacillus casei cell wall extract-induced murine model of Kawasaki disease[J]. Arthritis Rheumatol, 2017, 69(2): 410-421. PMID: 27696768. PMCID: PMC5274597. DOI: 10.1002/art.39939.
7 Xie Z, Huang Y, Li X, et al. Atlas of circulating immune cells in Kawasaki disease[J]. Int Immunopharmacol, 2022, 102: 108396. PMID: 34890998. DOI: 10.1016/j.intimp.2021.108396.
8 熊晓, 余理, 冯园, 等. 淋巴细胞亚群在儿科临床的应用[J]. 中华临床免疫和变态反应杂志, 2022, 16(5): 504-510. DOI: 10.3969/j.issn.1673-8705.2022.05.010.
9 McCrindle BW, Rowley AH, Newburger JW, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American Heart Association[J]. Circulation, 2017, 135(17): e927-e999. PMID: 28356445. DOI: 10.1161/CIR.0000000000000484.
10 Kobayashi T, Inoue Y, Takeuchi K, et al. Prediction of intravenous immunoglobulin unresponsiveness in patients with Kawasaki disease[J]. Circulation, 2006, 113(22): 2606-2612. PMID: 16735679. DOI: 10.1161/CIRCULATIONAHA.105.592865.
11 Egami K, Muta H, Ishii M, et al. Prediction of resistance to intravenous immunoglobulin treatment in patients with Kawasaki disease[J]. J Pediatr, 2006, 149(2): 237-240. PMID: 16887442. DOI: 10.1016/j.jpeds.2006.03.050.
12 Sano T, Kurotobi S, Matsuzaki K, et al. Prediction of non-responsiveness to standard high-dose gamma-globulin therapy in patients with acute Kawasaki disease before starting initial treatment[J]. Eur J Pediatr, 2007, 166(2): 131-137. PMID: 16896641. DOI: 10.1007/s00431-006-0223-z.
13 Yang S, Song R, Zhang J, et al. Predictive tool for intravenous immunoglobulin resistance of Kawasaki disease in Beijing[J]. Arch Dis Child, 2019, 104(3): 262-267. PMID: 30026252. DOI: 10.1136/archdischild-2017-314512.
14 Wu S, Liao Y, Sun Y, et al. Prediction of intravenous immunoglobulin resistance in Kawasaki disease in children[J]. World J Pediatr, 2020, 16(6): 607-613. PMID: 32232677. DOI: 10.1007/s12519-020-00348-2.
15 Lo MS. A framework for understanding Kawasaki disease pathogenesis[J]. Clin Immunol, 2020, 214: 108385. PMID: 32173601. DOI: 10.1016/j.clim.2020.108385.
16 Matsuguma C, Wakiguchi H, Suzuki Y, et al. Dynamics of immunocyte activation during intravenous immunoglobulin treatment in Kawasaki disease[J]. Scand J Rheumatol, 2019, 48(6): 491-496. PMID: 31272272. DOI: 10.1080/03009742.2019.1604992.
17 Zhang C, Zhang X, Shen J, et al. Changes in peripheral blood neutrophils, lymphocytes and IL-10 in children with Kawasaki disease from different age groups undergoing intravenous immunoglobulin: a retrospective study[J]. Mediators Inflamm, 2020, 2020: 5213451. PMID: 33293897. PMCID: PMC7691014. DOI: 10.1155/2020/5213451.
18 Ding Y, Li G, Xiong LJ, et al. Profiles of responses of immunological factors to different subtypes of Kawasaki disease[J]. BMC Musculoskelet Disord, 2015, 16: 315. PMID: 26497060. PMCID: PMC4619387. DOI: 10.1186/s12891-015-0744-6.
19 Burns JC, Hsieh LE, Kumar J, et al. Characterization of circulating immune cells in acute Kawasaki disease suggests exposure to different antigens[J]. Clin Exp Immunol, 2020, 202(3): 263-272. PMID: 32812215. PMCID: PMC7670149. DOI: 10.1111/cei.13506.
20 黎璇, 钱为国, 钱光辉, 等. 661 例川崎病急性期淋巴细胞亚群变化分析[J]. 中国血液流变学杂志, 2019, 29(2): 155-157. DOI: 10.3969/j.issn.1009-881X.2019.02.008.
21 Choi IS, Lee MJ, Choi SA, et al. Circulating immune cell profile and changes in intravenous immunoglobulin responsiveness over the disease course in children with Kawasaki disease[J]. Front Pediatr, 2022, 9: 792870. PMID: 35186822. PMCID: PMC8855096. DOI: 10.3389/fped.2021.792870.
22 李娜, 穆亚平, 陈静, 等. 淋巴细胞亚群绝对计数对儿童难治性肺炎支原体肺炎的早期预测作用[J]. 中国当代儿科杂志, 2019, 21(6): 511-516. PMID: 31208501. PMCID: PMC7389588. DOI: 10.7499/j.issn.1008-8830.2019.06.003.